Rosiptor

N/A

Report date: 2022/07/19 16:22:54
NME

Base Information

Drug NameRosiptor
Drug Alias NameRosiptor acetateAQX-1125
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionPhosphatidylinositol-3,4,5-trisphosphate 5-phosphatase 1 activators
TargetsPhosphatidylinositol-3,4,5-trisphosphate 5-phosphatase 1
Therapy Area/IndicationsPelvic PainDermatitis, AtopicCystitis, Interstitial +[5] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCzechiaBelgiumCanada +[16] 
CombinationsNo
Global Highest StatusDiscontinued (Phase 3 Clinical)
Highest Status in ChinaN/A
Originator CompaniesAquinox
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAstellas Pharma IncAquinox Pharmaceuticals (Canada) Inc
Active IndicationsN/A
Inactive IndicationsPelvic PainDermatitis, AtopicCystitis, Interstitial +[5] 

Other Information

ATC CodeN/A
Related LinksN/A